Pancreatic Cancer Research

ResearcherNippon Medical SchoolActive in the last 2 years

Akira Matsushita

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0800-9782; OpenAlex author ID A5087653357. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
51
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer. Co-author DOI 10.3389/fonc.2026.1902440↗
  2. Cancer‑associated fibroblast‑derived extracellular vesicles promote pancreatic cancer progression via the RAP1B/ANLN axis. Co-author DOI 10.3892/or.2026.9182↗
  3. Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection: A Nationwide Project Study of Japan Pancreas Society. Co-author DOI 10.1097/sla.0000000000006444↗
  4. Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis. Co-author DOI 10.1111/cas.16302↗
  5. Gp130-Mediated STAT3 Activation Contributes to the Aggressiveness of Pancreatic Cancer through H19 Long Non-Coding RNA Expression. Co-author DOI 10.3390/cancers14092055↗
  6. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. First author DOI 10.3892/or.2016.4727↗

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junji Ueda · 2 shared papers, 2026 · strength 0.50
  2. Kazufumi Honda · 2 shared papers, 2024–2026 · strength 0.48
  3. Ryuji Ohashi · 2 shared papers, 2024–2026 · strength 0.44
  4. Atsushi Masamune · 2 shared papers, 2025–2026 · strength 0.39
  5. Ayumi Kashiro · 1 shared paper, 2026 · strength 0.27
  6. Hiroshi Yoshida · 1 shared paper, 2026 · strength 0.23
  7. Kousuke Ishino · 1 shared paper, 2026 · strength 0.23
  8. Daigo Yoshimori · 1 shared paper, 2026 · strength 0.23
  9. Toshiyuki Ishiwata · 2 shared papers, 2016–2022 · strength 0.23
  10. Tomoaki Toyoda · 1 shared paper, 2024 · strength 0.21
  11. Shingo Kato · 1 shared paper, 2024 · strength 0.21
  12. Hisashi Yoshimura · 1 shared paper, 2022 · strength 0.16
  13. Yuuki Shichi · 1 shared paper, 2022 · strength 0.16
  14. Masashi Toyoda · 1 shared paper, 2022 · strength 0.16
  15. Fujiya Gomi · 1 shared paper, 2022 · strength 0.16
  16. Norihiko Sasaki · 1 shared paper, 2022 · strength 0.16
  17. Tamotsu Kuroki · 1 shared paper, 2025 · strength 0.16
  18. Hisato Igarashi · 1 shared paper, 2025 · strength 0.16
  19. Kenichi Hakamada · 1 shared paper, 2025 · strength 0.16
  20. Sohei Satoi · 1 shared paper, 2025 · strength 0.16
  21. Masayuki Furukawa · 1 shared paper, 2025 · strength 0.16
  22. Motokazu Sugimoto · 1 shared paper, 2025 · strength 0.16
  23. Shugo Mizuno · 1 shared paper, 2025 · strength 0.16
  24. Hidetoshi Eguchi · 1 shared paper, 2025 · strength 0.16
  25. Shuji Suzuki · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.